Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3852045 | American Journal of Kidney Diseases | 2007 | 13 Pages |
Abstract
For patients with ESRD with uncontrolled hyperparathyroidism who are good candidates for either drug therapy or surgery, cinacalcet hydrochloride is the most cost-effective modality if the patient is to remain on dialysis therapy for 7.25 ± 0.25 months. Cinacalcet may be more optimal if used in patients who have high risk of mortality or who would expect to receive a kidney transplant quickly. For other subgroups, parathyroidectomy dominated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Rajeev MD, Robert M. MD, Elizabeth P. MD, MPH, Christina M. MD, Robert T. MD, Eric S. MD, Fred E. MD, Gwenaelle M. MD, PhD, Kevin C. MD, MPH,